[Results of combined treatment of neoplasms of the posterior cranial fossa in children].
The effectiveness of combined treatment of posterior fossa tumours was analysed using the clinical material of a neurosurgery department. The material comprised 242 patients treated in the years 1980-1987 with 211 suboccipital craniotomies performed. In cases of cerebellar astrocytoma one-year survival rate was 9% and five year survival in 89% of cases. In the group of medulloblastoma treated in the period 1980-1982 the one-year survival rate was 75%, three-year 39% and five-year 25%. In the group treated in the years 1985-1987 the one-year survival rate was 95% and three-year was 60%. In ependymoma cases the one-year rate was 90%, three-year was 40% and five-year--33%. The use of combined treatment in cases of ependymoma and medulloblastoma improved significantly the therapeutic results.
Boratyński
W
W
Oddziału Neurochirurgii, Centrum Zdrowia Dziecka, Warszawie.
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001254:Astrocytoma / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D002528:Cerebellar Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D002648:Child; D002675:Child, Preschool; D003037:Cobalt Radioisotopes / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004806:Ependymoma / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D007223:Infant; D008130:Lomustine / Q000008:administration & dosage; D008297:Male; D008527:Medulloblastoma / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D011182:Postoperative Care; D011344:Procarbazine / Q000008:administration & dosage; D011379:Prognosis; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage
D003037:Cobalt Radioisotopes; D011344:Procarbazine; D014750:Vincristine; D008130:Lomustine
Wyniki leczenia skojarzonego nowotworów tylnego dołu czaszkowego u dzieci.